NDCFind

Amjevita 72511-0400

Generic: Adalimumab-Atto

Product NDC

72511-0400
Manufacturer
Amgen Usa Inc.
Dosage Form
Injection
Route
Subcutaneous
Product Type
Human Prescription Drug
Marketing Start
January 31, 2023
Listing Expires
December 31, 2026
Application
BLA761024
StockMeds — pharmacy-to-pharmacy marketplace

Need to source Amjevita? P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

IngredientStrength
Adalimumab40 mg/.8mL

Drug Class

Tumor Necrosis Factor Blocker [EPC]AntibodiesMonoclonal [CS]

Packaging Options(2)

1 SYRINGE in 1 CARTON (72511-400-01) / .8 mL in 1 SYRINGE

2 SYRINGE in 1 CARTON (72511-400-02) / .8 mL in 1 SYRINGE